ZECCHETTO, CAMILLA
 Distribuzione geografica
Continente #
NA - Nord America 1.929
EU - Europa 1.706
AS - Asia 1.136
SA - Sud America 179
Continente sconosciuto - Info sul continente non disponibili 55
AF - Africa 37
OC - Oceania 4
Totale 5.046
Nazione #
US - Stati Uniti d'America 1.867
RU - Federazione Russa 742
SG - Singapore 400
CN - Cina 350
IT - Italia 257
GB - Regno Unito 146
BR - Brasile 145
DE - Germania 140
VN - Vietnam 128
HK - Hong Kong 94
IE - Irlanda 91
SE - Svezia 82
FR - Francia 77
FI - Finlandia 59
CA - Canada 49
KR - Corea 37
IN - India 26
NL - Olanda 23
JP - Giappone 19
AR - Argentina 15
BD - Bangladesh 14
UA - Ucraina 14
AT - Austria 13
ES - Italia 13
TR - Turchia 12
PL - Polonia 11
ID - Indonesia 9
ZA - Sudafrica 9
BE - Belgio 6
BJ - Benin 6
EC - Ecuador 6
NG - Nigeria 6
SA - Arabia Saudita 6
TG - Togo 6
CZ - Repubblica Ceca 5
MX - Messico 5
AU - Australia 4
IQ - Iraq 4
JO - Giordania 4
LT - Lituania 4
PK - Pakistan 4
PT - Portogallo 4
UZ - Uzbekistan 4
HR - Croazia 3
NO - Norvegia 3
PY - Paraguay 3
TH - Thailandia 3
VE - Venezuela 3
AM - Armenia 2
AZ - Azerbaigian 2
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
NP - Nepal 2
PE - Perù 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
GI - Gibilterra 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
QA - Qatar 1
RE - Reunion 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.992
Città #
Ashburn 311
Moscow 302
Dallas 263
Singapore 226
Chandler 182
San Jose 175
Hong Kong 93
Dublin 91
Southend 86
Verona 70
Beijing 60
Munich 58
The Dalles 55
Ho Chi Minh City 46
Council Bluffs 45
New York 38
Los Angeles 34
Jacksonville 31
Helsinki 27
São Paulo 27
Turku 25
Jinan 24
Hanoi 22
Woodbridge 22
Tianjin 20
Houston 19
Lawrence 19
London 19
Montreal 19
Princeton 19
Santa Clara 19
Milan 18
Orem 17
Rome 17
Wilmington 17
Tokyo 16
Atlanta 15
Columbus 15
Shenyang 15
Toronto 15
Buffalo 14
Denver 14
Frankfurt am Main 14
Taiyuan 14
Chicago 12
Sindelfingen 12
Seattle 10
Ann Arbor 9
Barnet 9
Da Nang 9
Phoenix 9
Redondo Beach 9
Stockholm 9
Taizhou 9
Washington 9
Amsterdam 8
Paris 8
Seoul 8
Changsha 7
Jakarta 7
Johannesburg 7
Kent 7
Madrid 7
Monza 7
Redwood City 7
Vienna 7
Zhengzhou 7
Bologna 6
Boston 6
Cotonou 6
Fuzhou 6
Haikou 6
Hangzhou 6
Lomé 6
Nanjing 6
Nuremberg 6
San Francisco 6
Warsaw 6
Abuja 5
Brussels 5
Chennai 5
Guangzhou 5
Hebei 5
Mumbai 5
Nanchang 5
Treviso 5
Amman 4
Brasília 4
Brooklyn 4
Dhaka 4
Fairfield 4
Haiphong 4
Lancaster 4
Marseille 4
Miami 4
Ningbo 4
Quito 4
Redmond 4
Rio de Janeiro 4
Riyadh 4
Totale 3.003
Nome #
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 304
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 264
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 260
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 245
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 239
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 216
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 215
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 205
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 201
Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer 193
Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib 189
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer 184
Modulating TAK1 expression inhibits YAP and TAZ oncogenic functions in pancreatic cancer 181
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 180
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients 169
Targeting KRAS: The Elephant in the Room of Epithelial Cancers 167
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion 162
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma 160
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer 153
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 150
Pemigatinib, a potent inhibitor of FGFRs for the treatment of cholangiocarcinoma 148
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports 141
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 132
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear 123
Safety and activity of the TGF beta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer 123
Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers 121
Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials 112
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 94
Multicenter Phase I/Ii Trial of Gemcitabine, Oxaliplatin and Nab-Paclitaxel as First-Line Treatment for Patients with Advanced Biliary Tract Cancer 9
Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer 6
Totale 5.046
Categoria #
all - tutte 18.299
article - articoli 18.299
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022116 0 0 0 20 3 6 0 13 7 4 12 51
2022/2023498 24 63 36 81 37 137 0 30 63 7 13 7
2023/2024392 7 25 23 48 34 64 62 39 8 25 43 14
2024/2025797 37 32 40 123 37 38 79 37 74 35 108 157
2025/20262.444 135 120 239 407 627 151 228 104 203 162 35 33
2026/2027294 20 51 82 141 0 0 0 0 0 0 0 0
Totale 5.046